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abstract
 
Lidocaine produces voltage- and use-dependent inhibition of voltage-gated Na
 
1
 
 channels through
preferential binding to channel conformations that are normally populated at depolarized potentials and by slow-
ing the rate of Na
 
1
 
 channel repriming after depolarizations. It has been proposed that the fast-inactivation mech-
anism plays a crucial role in these processes. However, the precise role of fast inactivation in lidocaine action has
been difficult to probe because gating of drug-bound channels does not involve changes in ionic current. For that
reason, we employed a conformational marker for the fast-inactivation gate, the reactivity of a cysteine substituted
 
at phenylalanine 1304 in the rat adult skeletal muscle sodium channel 
 
a 
 
subunit (rSkM1) with [2-(trimethylam-
monium)ethyl]methanethiosulfonate (MTS-ET), to determine the position of the fast-inactivation gate during
lidocaine block. We found that lidocaine does not compete with fast-inactivation. Rather, it favors closure of the
fast-inactivation gate in a voltage-dependent manner, causing a hyperpolarizing shift in the voltage dependence of
site 1304 accessibility that parallels a shift in the steady state availability curve measured for ionic currents. More
significantly, we found that the lidocaine-induced slowing of sodium channel repriming does not result from a
slowing of recovery of the fast-inactivation gate, and thus that use-dependent block does not involve an accumula-
tion of fast-inactivated channels. Based on these data, we propose a model in which transitions along the activa-
tion pathway, rather than transitions to inactivated states, play a crucial role in the mechanism of lidocaine action.
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introduction
 
The gating of voltage-sensitive Na
 
1
 
 channels deter-
mines the time course of the rising phase of the action
potential and the length of the refractory period in
nerve, skeletal muscle, and heart. As a result, Na
 
1
 
 chan-
nels are the targets of several classes of drugs that mod-
ulate electrical excitability, including antiarrhythmics,
local anesthetics, antimyotonics, and anticonvulsants.
Among these, lidocaine and related local anesthetics
have received a great deal of experimental attention
because of their striking effects on Na
 
1
 
 channels: they
induce a voltage-dependent inhibition of the peak cur-
rent upon infrequent stimulation (tonic block), and
they dramatically slow repriming of sodium channels
after depolarizations (use-dependent block), thereby
preventing the repetitive discharges that occur in car-
diac arrhythmia, epilepsy, and myotonia (Butterworth
and Strichartz, 1990).
Several experimental findings implicate a role for the
Na
 
1
 
 channel fast inactivation mechanism in generating
these effects: depolarization favors local anesthetic
binding, many local anesthetics shift the steady state
availability (
 
h
 
`
 
) curve in the hyperpolarizing direction
(Bean et al., 1983; Hille, 1977), and fast-inactivationÐ
defective Na
 
1
 
 channels are more resistant to some of
the effects of local anesthetics than are normal chan-
nels (Cahalan, 1978; Wang et al., 1987; Yeh and Tan-
guy, 1985).
However, a number of questions remain. Is there co-
operativity, negative or positive, between lidocaine and
the fast-inactivation gate? Does use-dependent block in-
volve an accumulation of fast-inactivated sodium chan-
nels? Is there a direct, mutually stabilizing interaction
between lidocaine binding and closure of the fast-inac-
tivation gate? Answers to these questions have been dif-
ficult to obtain, primarily because gating transitions
that occur in drug-bound channels do not involve
changes in ionic current, and are thus electrophysio-
logically silent. Indeed, neither the ionic current nor
the gating current provides direct information about
the position of the fast-inactivation gate during local
anesthetic block.
To circumvent this difficulty, we have employed a con-
formational marker for the position of the fast-inactiva-
tion gate, the reactivity of a cysteine substituted for phe-
nylalanine 1304 in the rat adult skeletal muscle sodium
 
channel 
 
a 
 
subunit
 
 
 
with the thiol-modifying reagent
[2-(trimethylammonium)ethyl]methanethiosulfonate
(MTS-ET).
 
1
 
 Site 1304 lies in the sodium channel IIIÐIV
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Abbreviation used in this paper:
 
 MTS-ET, [2-(trimethylammo-
nium)ethyl]methanethiosulfonate. 
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interdomain and plays a crucial role in fast inactivation
(West et al., 1992). In a previous study, we have demon-
strated that the reaction rate of the substituted cysteine
with MTS-ET follows closely the voltage dependence of
steady state fast inactivation (Vedantham and Cannon,
1998). This has enabled us to use this reaction rate as a
measure of the fraction of channels whose fast-inactiva-
tion gates are shut under conditions of particular interest.
In this study, we have determined the position of the
fast-inactivation gate in channels that are bound to the
local anesthetic drug lidocaine under several experi-
mental conditions. We found that lidocaine does not
compete with closure of the fast-inactivation gate; on
the contrary, the fraction of blocked channels that are
fast inactivated increases with depolarization and with
drug concentration. More surprisingly, our data show
that recovery from fast inactivation precedes recovery
of the ionic current in drug-bound channels and is just
as fast as recovery in the absence of drug, demonstrat-
ing that use-dependent block does not involve an accu-
mulation of fast-inactivated channels. Based on these
findings, we propose a model in which lidocaine bind-
ing affinity is modulated by gating transitions along the
activation pathway, without a direct interaction be-
tween lidocaine binding and fast inactivation.
 
materials and methods
 
Expression of Na
 
1
 
 Channels 
 
The construction of cDNAs encoding F1304C and human Na
 
1
 
channel 
 
b
 
1
 
 subunit in pGEMHE is described in Vedantham and
Cannon (1998). RNA for F1304C and 
 
b
 
1
 
 subunit were all gener-
ated by in vitro translation of linearized plasmids (Message
Machine kit; Ambion Inc.). 
 
Xenopus 
 
oocytes were harvested and
coinjected with F1304C 
 
1
 
 human 
 
b
 
1
 
 RNA as described in
Chen  and Cannon (1995). Before electrophysiological record-
ing, oocytes were incubated for 2Ð3 d at 18
 
8
 
C in ND-96 (96 mM
NaCl, 2 mM KCl, 1.8 mM CaCl
 
2
 
, 1 mM MgCl
 
2
 
, 5 mM HEPES,
pH 7.6) supplemented with pyruvate (2.5 mM) and gentamicin
(50 
 
m
 
g/ml).
 
Electrophysiology 
 
Recording conditions and solution exchange were as described
in Vedantham and Cannon (1998). The pipette solution con-
tained (mM): 100 NaCl, 10 HEPES, 2 CaCl
 
2
 
, 1 MgCl
 
2
 
, pH 7.6.
The bath contained 100 KCl, 10 HEPES, 5 EGTA, 1 MgCl
 
2
 
, pH
7.6. Lidocaine powder (hydrochloride salt; Sigma Chemical Co.)
was added to the bath solution in appropriate amounts to obtain
a final concentration of 0.5, 1, 2, 4, or 8 mM lidocaine. Stock so-
lutions (2 mM) of MTS-ET (Toronto Research Chemicals Inc.)
were prepared from the solid in 1 ml of distilled, deionized H
 
2
 
O
and placed on ice at the beginning of each recording day. Appro-
priate amounts were diluted into 10 ml of bath solution (to a fi-
nal concentration of 8 
 
m
 
M) after suitable patches were obtained
and immediately before use. MTS-ET solutions were never used
for 
 
.
 
10 min after dilution from the stock. Our method for deter-
mining the fidelity of solution exchange is described in Vedan-
tham and Cannon (1998), with one change: patches in which the
 
seal formed without suction were included in the data set even if
they did not last long enough for a switching test (such patches
invariably exhibited rapid exchange kinetics).
 
Data Analysis
 
Curve fitting was performed off line using a custom AxoBasic
analysis program (Axon Instruments, Inc.) or SigmaPlot (Jandel
Scientific Co.). Steady state fast inactivation, 
 
h
 
`
 
, and the voltage
dependence of the modification rate were fitted to Boltzmann
curves with maximum values, 
 
I
 
max
 
, and nonzero pedestals, 
 
c
 
, cal-
culated as 
 
I
 
/
 
I
 
peak
 
 
 
5 
 
[
 
I
 
max
 
 
 
2 
 
c
 
]/{1 
 
1
 
 exp[(V 
 
2 
 
V
 
1/2
 
)/
 
k
 
]} 
 
1
 
 
 
c,
 
where V
 
1/2
 
 is the voltage at half maximum, and 
 
k
 
 is the slope fac-
tor. Error bars indicate means 
 
6
 
 SEM.
For modification experiments, the fraction modified after a
given pulse of MTS-ET was calculated by averaging the value of
the Na
 
1
 
 current between 3 and 3.5 ms after depolarization to
 
2
 
20 mV. For each experiment, the fraction modified (
 
F
 
) versus
cumulative exposure time (
 
t
 
exp
 
) were fit to a monoexponential:
 
F
 
 
 
5 
 
(
 
I
 
max 
 
2 
 
F
 
o
 
)[1 
 
2 
 
exp(
 
2
 
t
 
exp
 
/
 
t
 
mod
 
)] 
 
1 
 
F
 
o
 
, where 
 
t
 
mod
 
 is the re-
ciprocal of the reaction rate, 
 
F
 
o
 
 is the mean value of the current
between 3 and 3.5 ms before any exposure has occurred, and
 
I
 
max
 
, the maximum value of the mean current between 3 and 3.5
ms, was a free parameter in the fit.
 
results
 
Modification of F1304C by MTS-ET in the Presence
of Lidocaine
 
All experiments were conducted in excised inside-out
patches pulled from 
 
Xenopus 
 
oocytes coinjected with
rat  adult skeletal muscle sodium channel 
 
a
 
 subunit
F1304C and human 
 
b
 
1
 
 subunit RNA. Fig. 1 A shows
macroscopic current traces elicited by depolarization
from 
 
2
 
120 to 
 
2
 
20 mV before and after a 5-s applica-
tion of 8 
 
m
 
M MTS-ET to the intracellular side. As re-
ported previously for this channel (Vedantham and
Cannon, 1998) and for the rat brain IIA homologue
(Kellenberger et al., 1996), MTS-ET modification
causes an increase in the peak current and a dramatic
disruption of fast inactivation, consistent with the im-
portance of F1304 (F1489 in the brain IIA channel) for
fast inactivation (West et al., 1992).
As in the absence of lidocaine, MTS-ET increases the
peak current and disrupts fast inactivation in the pres-
ence of 1.0 mM lidocaine (Fig 1 B). However, block by
lidocaine reduces the apparent fraction of channels
that fail to inactivate and attenuates the increase in
peak current associated with MTS-ET modification.
These effects of lidocaine on F1304C-ET are similar to
its effects on fast inactivationÐdefective Na
 
1
 
 channels
studied in other contexts (Balser et al., 1996; Bennett
et al., 1995; Wang et al., 1987). When lidocaine is sub-
sequently washed out, the current traces were indistin-
guishable from the case when no lidocaine was present
during the modification (data not shown), demonstrat-
ing that lidocaine does not prevent the modification re-
action from reaching completion. 
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Measurement of the Modification Rate of in the Presence
of Lidocaine
 
For accurate measurement of the rate of modification
of F1304C by MTS-ET, we used a rapid perfusion sys-
tem (Vedantham and Cannon, 1998) to apply con-
trolled, brief exposures of MTS-ET to the intracellular
face of inside-out patches. Fig. 2 A shows an example of
such an experimental protocol: a series of 20-ms expo-
sures to 8 
 
m
 
M MTS-ET at 
 
2
 
120 mV, with a test pulse
used to assay the macroscopic current between each ex-
posure. The rate of modification was determined by av-
eraging the value of the macroscopic current between
3.0 and 3.5 ms after depolarization (Fig. 2 B), plotting
the averages from successive traces against cumulative
exposure time, and fitting the resulting curve with a
monoexponential (Fig. 2 C). For the experiment
shown in Fig. 2, the time constant of this curve was 0.16 s,
giving a rate of 0.781 
 
m
 
mol
 
2
 
1 
 
s
 
2
 
1
 
.
Figure 1. Modification of F1304C with MTS-ET in the presence
of lidocaine. (A) Na1 currents recorded from inside-out patches
excised from Xenopus oocytes injected with m1 F1304C and human
b1 subunit are shown before and after 5 s of exposure to 8 mM
MTS-ET. Each trace is an average of 10 individual depolarizations
from 2120 to 220 mV. F1304C-ET has an increased peak current
(62%) and a dramatic failure of inactivation as compared with un-
modified F1304C. B shows experiments performed as in A with 1.0
mM lidocaine added to the bath. Under these conditions, MTS-ET
causes a modest increase in peak current (22%). Lidocaine re-
duces the steady state current of unmodified F1304C and causes
partial current decay of the noninactivating F1304C-ET current.
Figure 2. Measurement of the rate of MTS-ET modification of
F1304C in the presence of lidocaine. The experimental protocol
shown in A consists of a series of 20-ms exposures of excised inside-
out patches to 8 mM MTS-ET with test pulses between each expo-
sure. 1.0 mM lidocaine was present at all times. In B, selected
traces from the modification experiment described in A are super-
imposed. To determine the degree of modification after each
trace, the value of the macroscopic current between 3 and 3.5 ms
after depolarization was averaged. Rates were determined by fit-
ting the degree of modification of each trace as a function of cu-
mulative exposure time with a monoexponential containing a
maximum value after complete modification, a nonzero initial
value before modification, and a time constant as free parameters.
C shows these averages, normalized to the difference between the
maximum value and the initial value, plotted against cumulative
exposure time, with the normalized curve fit superimposed. 
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Concentration Dependence of Site 1304 Accessibility in 
Lidocaine-bound Channels
 
We estimated tonic block in F1304C by measuring the
peak current elicited from excised inside-out patches
by infrequent depolarization from 
 
2
 
120 to 
 
2
 
20 mV
under control conditions, in the presence of a fixed
concentration of lidocaine applied to the intracellular
face (0.1, 0.5, 1.0, 2.0, 4.0, or 8.0 mM), and then back
in control solution. The fraction of tonic block was ob-
tained by dividing the peak current measured in the
presence of lidocaine by the average of the peak cur-
rent measured before exposure to lidocaine and after
washout. These data (Fig. 3, 
 
d
 
) were fit to a binding
curve with a hill coefficient of 1.0, yielding a 
 
K
 
d
 
 of 1.9 mM.
We compared the relative accessibility of site 1304 to
the degree of tonic block at specific lidocaine concen-
trations by dividing the modification rate in the pres-
ence of 0.5, 1.0, 2.0, or 4.0 mM lidocaine by the rate
measured with no lidocaine present (Fig. 3, 
 
s
 
). We
found that the accessibility of site 1304 was less sensitive
to lidocaine than the peak current (
 
K
 
a
 
 
 
5 
 
6.6, as com-
pared with 1.9), indicating that, at 
 
2120 mV and
lidocaine concentrations below the Kd, the majority of
tonic block is caused by lidocaine binding to noninacti-
vated Na1 channels. However, as drug concentration is
increased, the fraction of inactivated channels appears
to increase as well, although we cannot rule out the
possibility that nonspecific effects cause the reduction
of reaction rate at such high drug concentrations.
The Voltage Dependence of Site 1304 Accessibility Is Shifted in 
the Presence of Lidocaine
We confirmed that lidocaine causes a hyperpolarizing
shift in the steady state availability curve for F1304C us-
ing 1.0 mM lidocaine. In five experiments, the steady
state availability curve was measured with 200-ms
prepulses, first in control solution, and then in 1.0 mM
lidocaine. Each curve was fit independently to a Boltz-
mann (Fig. 4). We observed a hyperpolarizing shift in
the half-maximal voltage (10.8 6 2.6 mV), and a reduc-
tion in the maximum value of 22 6 6%.
Although such a shift strongly suggests a stabilizing
effect of lidocaine on fast-inactivated channels, it is in
Figure 3. Effect of tonic block on accessibility of site 1304. Tonic
block of F1304C (d) was evaluated by dividing the peak current
obtained from infrequent depolarizations to 220 from 2120 mV
in the presence of 0.1, 0.5, 1.0, 2.0, 4.0, or 8.0 mM lidocaine by the
peak current in the absence of drug (n 5 4 for each point). These
data were fit to a binding curve with a hill coefficient of 1.0, giving
a Kd of 1.9 mM. Also shown in the graph is the modification rate of
F1304C with 8 mM MTS-ET at 2120 mV in the presence of 0.5 (n 5
4), 1.0 (n 5 10), 2.0 (n 5 8), or 4.0 (n 5 10) mM lidocaine divided
by the rate measured without lidocaine present (n 5 4) (s). The
rates were measured using the protocol shown in Fig. 2 A. A fit to
the modification rate data gives a Ka of 6.6 mM.
Figure 4. Effect of lidocaine on the steady state availability curve
of F1304C. h` curves were recorded with 200-ms prepulses, fol-
lowed by a test pulse to 220 mV. For each patch, the h` curve was
measured in the absence and presence of 1.0 mM lidocaine (n 5
5) in rapid succession. In other experiments without lidocaine, we
did not observe significant left shifts in gating after patch excision
on the time scale of these experiments. Data from each curve was
fit with a Boltzmann with maximal value (Imax), half-maximal volt-
age (V1/2), slope (k), and nonzero plateau (c) as free parameters.
The graph shows data normalized to the maximum value for
curves measured in the absence of lidocaine, and then averaged
across trials. Without lidocaine, V1/2 5 278.9 6 1.9 mV, k 5 6.2 6
0.7 mV, and c 5 0.11 6 0.02. In 1.0 mM lidocaine, V1/2 5 289.7 6
1.8 mV, k 5 7.1 6 0.4 mV, c 5 0.08 6 0.02, and Imax in 1.0 mM
lidocaine was 78 6 6% of Imax in the absence of lidocaine. This rep-
resents a hyperpolarizing shift in the apparent h` curve by 10.8 6
2.6 mV.11 Vedantham and Cannon
principle possible that the decrease in available chan-
nels due to lidocaine does not involve closure of the
fast-inactivation gate, but rather to the intrinsic proper-
ties of drug-block. Indeed, a hyperpolarizing shift in
the apparent h` curve does not preclude the possibility
of competition between lidocaine binding and closure
of the fast-inactivation gate (for example, if lidocaine
and the fast-inactivation gate compete for a single bind-
ing site). In the case of a stabilizing interaction, the
voltage dependence of site 1304 accessibility should
shift in the same direction as the steady state availability
curve, while in the case of competition it would not.
We therefore measured the modification rate at a va-
riety of conditioning voltages using the protocol shown
in Fig. 5 A in the absence of lidocaine (Fig 5 B, d), and
in the presence of 1.0 mM lidocaine (Fig. 5 B, s). The
data were fit with Boltzmanns containing maximum
rates (Rmax), minimum rates (Rmin), slope (k), and half-
maximal voltage (V1/2) as free parameters. With no
lidocaine present, Rmax 5 0.71 mmol21 s21, Rmin 5 0.12
mmol21 s21, k 5 3.3 mV, and V1/2 5 279.7 mV; while in
1.0 mM lidocaine, Rmax 5 0.68 mmol21 s21, Rmin 5 0.08
mmol21 s21, k 5 6.6 mV, and V1/2 5 289.9 mV.
The voltage at half-maximal modification is shifted
by 10.2 mV in the hyperpolarizing direction, similar to
the 10.8-mV shift seen in the steady state availability
curves (Fig. 2 A). Thus, depolarization increases the
fraction of blocked channels that are inactivated: at
2120 mV, very few of the blocked channels are inacti-
vated, while at 290 mV, nearly all of the blocked chan-
nels (z40Ð50% of the total) are inactivated. Both the
direction of the voltage shift and the fact that Rmin is
unchanged demonstrate that lidocaine does not com-
pete with the fast-inactivation gate. Rather, it tends to
favor closure of the fast gate in a voltage-dependent
manner. Also, the Rmax was not significantly different
for control and 1.0 mM lidocaine. To confirm this con-
vergence of Rmax values, further experiments were per-
formed at conditioning voltages of 2160 and 2200
mV. We found no significant difference between con-
trol and 1.0 mM lidocaine conditions (data not shown).
Lidocaine Does Not Impede Recovery of Site 1304 Accessibility
Use-dependent block results from the slowing of the re-
covery of Na1 channel availability, and explains the
ability of lidocaine to prevent rapid, high-frequency dis-
charges in excitable tissues (Bean et al., 1983). We mea-
sured this effect in F1304C inside-out macropatches us-
ing a two-pulse recovery protocol with a 20-ms condi-
tioning pulse to 0 mV, a variable recovery period, and a
test pulse to 0 mV. The peak current from the test pulse
divided by the peak current from the conditioning
pulse is a measure of the amount of repriming that
takes place during the recovery period. Experiments
were performed in control solution (Fig. 6, d), and in
1 mM lidocaine (Fig. 6, s). Consistent with previous
studies, lidocaine dramatically slowed recovery of Na1
channel availabilityÑby z100-fold under our experi-
mental conditions.
If use-dependent block involves accumulation of fast-
inactivated channels, then the accessibility of site 1304
should be reduced for hundreds of milliseconds after a
brief depolarization, in accordance with the reduction
in Na1 channel availability. However, if recovery from
fast inactivation is unaffected by lidocaine, then the ac-
cessibility of site 1304 after a short depolarization
should not change in the presence of lidocaine, even
though Na1 channel availability is reduced.
The protocol we used to resolve this issue (Fig. 7 A)
consisted of a series of 20-ms conditioning pulses to 0
Figure 5. Effect of lidocaine on the voltage dependence of site
1304 accessibility. The rate of MTS-ET modification of F1304C was
measured at a variety of voltages, as shown in A. Excised, inside-out
patches underwent a series of 300-ms depolarizations: 200 ms to
achieve steady state fast inactivation, followed by 50 ms for expo-
sure to 8.0 mM MTS-ET, and a final 50-ms period after exposure to
insure complete washout of MTS-ET before repolarization. After
each 300-ms depolarization, the patch was maintained at 2120 mV
for enough time to insure complete recovery (2Ð8 s, depending on
the conditioning voltage) before assaying macroscopic current
with a test pulse to 220 mV. Modification rates are shown in B
when the experiments were conducted in the absence (d) and
presence (s) of 1.0 mM lidocaine. (On average, n 5 6, n 5 at least
3 for each point.)12 Lidocaine and Na1 Channel Inactivation
mV, each followed by a brief, experimentally measured
7.5-ms delay at 2120 mV, and then a 20-ms exposure to
8 mM MTS-ET, also at 2120 mV. Relative to the time
course of Na1 channel repriming, the duration of MTS-
ET exposure corresponds to the shaded area of Fig. 6
B. After each depolarization and MTS-ET exposure,
sufficient time was allowed for complete recovery be-
fore assaying the macroscopic current. Experiments
were performed in control solution and in 1.0 mM
lidocaine. Averages of modification time courses, anal-
ogous to the individual time course in Fig. 2 C, are
shown in Fig. 7 B (d, control; s, 1.0 mM lidocaine).
The reaction rates were not significantly different for
the two conditions: 0.63 6 0.07 mmol21 s21 for control,
and 0.60 6 0.07 mmol21 s21 for 1.0 mM lidocaine, and
are within 10Ð14% of Rmax, the maximum rate of modi-
fication estimated from the data of Fig. 5. The dashed
line shows the modification time course that would be
expected if site 1304 accessibility mirrored the availabil-
ity of Na1 current (z0.13 mmol21 s21; see Fig. 7 legend
for calculation). These data demonstrate that recovery
from fast inactivation is not significantly affected by lido-
caine, and thus that use-dependent block does not in-
volve the accumulation of fast-inactivated Na1 channels.
Figure 6. Lidocaine slows the repriming of Na1 channels after
brief depolarizations. A two-pulse recovery protocol was used to as-
sess the rate of repriming of F1304C channels after a 20-ms depo-
larization to 0 mV. The peak current measured during the test
pulse was divided by the peak current measured during the condi-
tioning pulse, and plotted as a function of the recovery period. In
the absence of lidocaine, the current recovered almost completely
within 10 ms, while in the presence of 1.0 mM lidocaine, the time
constant of recovery is roughly 100-fold slower. The shaded area
indicates the duration of MTS-ET exposure relative to Na1 chan-
nel repriming for the protocol shown in Fig. 7 A.
Figure 7. Lidocaine does not slow the return of site 1304 accessi-
bility after brief depolarizations. In the protocol diagrammed in A,
20-ms exposures to 8 mM MTS-ET were timed to occur 7.5 ms after
20-ms depolarizations to 0 mV. The macroscopic current was as-
sayed between each exposure, and modification rates were mea-
sured as shown in Fig. 2. The 7.5 ms reflects the experimentally
measured delay between the voltage command to the piezoelectric
stack (which occurred exactly at the end of the conditioning
pulse) and the commencement of solution exchange (for details,
see Vedantham and Cannon, 1998). B shows the average of several
modification experiments conducted with or without 1.0 mM
lidocaine. The solid lines are exponentials whose time constants
are the mean values of the time constants obtained from fits to
data from individual experiments. The dashed line reflects the
curve that would be expected if the accessibility of site 1304 paral-
leled the degree of Na1 channel availability in 1.0 mM lidocaine
during the exposure. The fraction of current recovered in the
presence of 1.0 mM lidocaine after 8-, 10-, and 20-ms recovery
times was averaged (corresponding to the shaded area in Fig. 6),
giving 0.2962. An accessibility of 0.30 predicts a rate of 2.1 s21 at 8
mM MTS-ET (predicted rate 5 0.30 3 (Rmax 2 Rmin) 1 Rmin), or
0.26 mmol21 s21.13 Vedantham and Cannon
discussion
Accessibility of Site 1304 During Lidocaine Block
The major findings of this study are that (a) lidocaine
does not compete with the fast-inactivation gate, (b)
lidocaine potentiates the degree to which depolariza-
tion favors closure of the fast-inactivation gate, and (c)
lidocaine does not measurably affect the rate of recov-
ery of the fast-inactivation gate. These observations
were made possible by our ability to follow the position
of the fast-inactivation gate with a conformational
marker, the reactivity of site 1304 with MTS-ET, charac-
terized in detail in a previous study (Vedantham and
Cannon, 1998).
In the first set of experiments, we determined the
position of the fast-inactivation gate as a function of
lidocaine concentration during tonic block, the inhibi-
tion of peak sodium current that occurs with infre-
quent depolarization. Our results indicate that at 2120
mV, for lidocaine concentrations below the Kd for
block, the majority of blocked channels are not fast-
inactivated. Above the Kd for block, the data suggest
that lidocaine favors closure of the fast-inactivation
gate, although the certainty of this conclusion is under-
mined by the possibility of nonspecific effects interfer-
ing with the reaction between MTS-ET and site 1304 at
such high drug concentrations. (Our data on the volt-
age dependence of the reaction rate show that nonspe-
cific reduction of the reaction rate is not occurring at
1.0 mM lidocaine: the reaction rates in 1.0 mM
lidocaine and control conditions are equal at very hy-
perpolarized voltages.)
Assuming that the modification rate faithfully reports
the position of the fast-inactivation gate even above the Kd
for tonic block, our observations on concentration de-
pendence are consistent with state-dependent binding of
lidocaine to channel conformations that are populated
significantly only at depolarized potentials in the absence
of drug. As the lidocaine concentration is increased,
the population of channels that are in these Òdepolar-
izedÓ conformations will increase by mass action, even
at 2120 mV. Because depolarized states favor closure
of the fast-inactivation gate, increasing lidocaine con-
centration should also favor closure of the fast gate.
That the modification rate is reduced by 40Ð50% in
the presence of 4.0 mM lidocaine at 2120 mV predicts
a dramatically altered h` curve: at 2120 mV, a signifi-
cant fraction of channels must be unavailable. We
found, consistent with our data, that in 4.0 mM
lidocaine, availability at 2120 mV is somewhere on the
steep portion of the h` curve, although we could not
accurately estimate the relative availability at 2120 mV
because patches do not survive the strong hyperpolar-
izations (less than 2140 mV) that would be required to
determine the maximum availability (data not shown).
Our next set of experiments on the voltage depen-
dence of site 1304 accessibility in the presence of
lidocaine showed a 10.2-mV hyperpolarizing shift of
the half-maximal modification rate, similar to the 10.8-
mV hyperpolarizing shift of the V1/2 of the h` curve.
However, Rmax and Rmin were not significantly changed,
even though the maximum value of the h` curve was re-
duced by 22% in 1.0 mM lidocaine.
Most state-dependent models predict that block at
very hyperpolarized voltages reflects binding of drug to
noninactivated channels. Rmax, the limiting modifica-
tion rate at such hyperpolarized voltages, reflects the
position of the fully accessible fast-inactivation gate and
should not, according to a state-dependent model, be
reduced in the presence of 1.0 mM lidocaine, even if
22% of the channels are blocked. As the channels are
depolarized, however, a state-dependent mechanism fa-
vors binding to channels further along in the activation
pathway and predicts that the fraction of blocked chan-
nels that are fast-inactivated will increase. This explains
the observed left shift of the voltage dependence of the
modification rate. Rmin, which reflects the maximal de-
gree of gate closure in F1304C, is not significantly
changed in the presence of lidocaine, a finding that is
also predicted by a state-dependent mechanism favor-
ing inactivation.
The final set of experiments was directed at the effect
of lidocaine on the recovery of site 1304 accessibility af-
ter brief depolarizing pulses. We first confirmed that
1.0 mM lidocaine dramatically slows the recovery of
F1304C availability at 2120 mV after a 20-ms depolar-
ization to 0 mV. In the absence of lidocaine, the time
constant of recovery is on the order of 1Ð2 ms, while in
1.0 mM lidocaine, it is z100Ð200 ms. This effect pro-
duces use-dependent block, a frequency-dependent,
cumulative inhibition of sodium current with repetitive
depolarizations. Between 7.5 and 37.5 ms, only z20Ð
30% of channels recover in the presence of lidocaine,
whereas .90% recover with no lidocaine present. By
contrast, the modification rate was not changed at all in
the presence of 1.0 mM lidocaine, demonstrating that
lidocaine does not significantly alter the kinetics of re-
covery from fast inactivation.
A Possible Mechanism of Lidocaine Action
At first glance, the results of these experiments seem to
be in conflict: on the one hand, lidocaine shifts the h`
curve in a way that favors fast inactivation, suggesting a
stabilizing interaction between lidocaine block and fast-
inactivated channels. On the other hand, lidocaine has
no measurable effect on the off rate of the fast-inactiva-
tion particle, suggesting that it does not preferentially
stabilize fast inactivation.
One model that reconciles our results is shown in
Fig. 8. Following Kuo and Bean (1994), we employ a14 Lidocaine and Na1 Channel Inactivation
model for sodium channel gating consisting of several
closed, noninactivated states, each in equilibrium with
a fast-inactivated state (Fig. 8 A). For convenience, only
a few such equilibria are depicted. Horizontal equilib-
ria represent the voltage-dependent transitions along
the activation pathway, with depolarization favoring a
rightward shift in the distribution of populated states.
The vertical transitions, by contrast, are voltage inde-
pendent, and the rightmost equilibria favor inactivated,
rather than noninactivated, channels. According to this
model, depolarization moves the distribution of chan-
nels to the right and down, while hyperpolarization
tends to shift the distribution to the left and up.
Fig. 8 B presents a qualitative model for how
lidocaine affects the states depicted in Fig. 8 A. We as-
sume that each state can bind lidocaine, since our data
suggest that both inactivated and noninactivated chan-
nels may experience block. We incorporate state de-
pendence by postulating that lidocaine binds more fa-
vorably to channels that are further along in the activa-
tion pathway (towards the right), regardless of whether
they are noninactivated or inactivated. In other words,
lidocaine is sensitive to position along the horizontal,
voltage-dependent axis of the state diagram, but not
the vertical, voltage-independent axis. In this model,
lidocaine does not directly affect the equilibrium con-
stants between inactivated and noninactivated channels
(the equilibrium distributions for Cn « In and CnL «
InL are equal). Consequently, lidocaine binding does
not affect the rate of recovery from fast inactivation by
very much, in agreement with our findings on the re-
covery of accessibility of site 1304. However, the volt-
age-dependent equilibria in the activation pathway are
altered in lidocaine-bound channels, shifting the over-
all distribution of channels to the right in Fig. 8 B.
The model also explains why lidocaine causes a hy-
perpolarizing shift in the h` curve. By mass action, addi-
tion of lidocaine at any given voltage will tend to shift
the distribution of channels towards the right in the
state diagram of Fig. 8 B. Since the vertical equilibria
will favor fast-inactivated states as the distribution of
channels moves sufficiently rightward along the activa-
tion pathway, the addition of lidocaine will indirectly
promote fast inactivation. This phenomenon also ex-
plains our tonic block measurements: the greater the
lidocaine concentration, the greater the rightward shift
along the activation pathway, and hence the greater the
fraction of inactivated channels.
The model also predicts a reciprocal effect of fast in-
activation on lidocaine action: the presence of the fast-
inactivation gate promotes block, because (like lido-
caine) the fast-inactivation particle binds more tightly
to the rightmost states on the activation pathway. This
would partly explain why channels with disrupted fast
inactivation show a reduction in sensitivity to lidocaine
effects (Cahalan, 1978; Yeh, 1978; Bennett et al., 1995;
Balser et al., 1996). We need not attribute this reduc-
tion in sensitivity to an essential role played by inactiva-
tion in the mechanism of lidocaine action.
Use-dependent block, in our model, is a conse-
quence of a slow off rate of drug from the drug-bound,
nonÐfast-inactivated states. Recall that at depolarized
potentials, our data show that both lidocaine and the
Figure 8. A model for lidocaine action. In A, a section of the ac-
tivation pathway for sodium channels is shown, in which each non-
inactivated state (Cn) is connected to an inactivated state (In). The
length of the vertical arrows between inactivated and noninacti-
vated states indicate the degree to which the equilibrium favors in-
activated channels: the longer the arrow, the greater the fraction
of inactivated channels. Thus, depolarization causes rightward
movement and increases the fraction of inactivated channels. In B,
a set of states is added to the model that incorporate lidocaine
binding. The arrows that move between unbound (Cn or In) and
lidocaine-bound states (CnL or InL) indicate the degree to which
the equilibrium favors lidocaine binding: the longer the arrow, the
greater the fraction of lidocaine-bound channels. Thus, as for the
case of inactivation, depolarization favors lidocaine block as well as
inactivation. The model implies that addition of lidocaine causes a
rightward shift in the distribution of channels owing to coupling
between activation and lidocaine binding, while the vertical equi-
libria experience no such coupling (explaining why recovery from
fast inactivation is not altered in lidocaine-bound channels). The
rightward movement of the distribution will tend to increase the
fraction of channels that are inactivated, thereby causing a shift in
the h` curve. The slowing of repriming is a result of the slow disso-
ciation of lidocaine from the CnL states.15 Vedantham and Cannon
fast-inactivation particle are bound (i.e., the back,
lower row in Fig 8 B is populated), and that on repolar-
ization the fast-inactivation particle dissociates rapidly,
populating the back, upper row of Fig. 8 B. The transi-
tions from the back, upper row to the front, upper row,
along with full leftward movement along the activation
pathway, is rate limiting and slow (100-fold slower than
recovery from fast inactivation), and generates use-
dependent block when further depolarization occurs
before full recovery.
A remaining question concerns the kinetics of left-
ward movement along the activation pathway upon re-
polarization. Because inactivation is not intrinsically
voltage dependent, but derives its voltage dependence
from activation, some leftward movement along the ac-
tivation pathway must precede recovery from inactiva-
tion. In other words, some inward charge movement
must occur if recovery from inactivation is to occur.
Unfortunately, whether and to what extent lidocaine
impedes inward charge movement upon repolarization
has not been examined carefully. Our results predict
that some component of the gating charge must re-
main relatively free to move even in lidocaine-bound
channels, and that inward movement of this fraction
must be sufficient for complete recovery of the fast-
inactivation gate. Further experiments will be required
to elucidate the details of the coupling between inacti-
vation and gating charge movement in the presence of
lidocaine, and thereby to determine how far the distri-
bution of channels must move to the left on repolariza-
tion for full recovery from inactivation to occur.
Relation to Previous Work on Lidocaine
Our model is a version of the modulated receptor hy-
pothesis (Hille, 1977; Hondeghem and Katzung, 1977),
in which the affinity of a single receptor site for
lidocaine is altered by the conformational state of the
channel. Our model differs from HilleÕs original pre-
sentation and from that of Bean et al. (1983) by not
treating the inactivated state as the high-affinity state.
Instead, we propose that transitions along the activa-
tion pathway (outward movement of S4 segments and/
or opening of the activation gate) affect the affinity of
lidocaine for its receptor, following the proposals of
Wang et al. (1987), Strichartz and Wang (1986), and
Yeh and Tanguy, 1985. Several lines of evidence sup-
port our hypothesis.
First, numerous studies have shown a reduction in
the potency of local anesthetics in fast-inactivation de-
fective sodium channels (Cahalan, 1978; Yeh, 1978;
Bennett et al., 1995; Balser et al., 1996). However, de-
spite the loss of potency, local anesthetics do retain
their ability to generate tonic and use-dependent block
in these channels (Shepley et al., 1983; Strichartz and
Wang, 1986; Wang et al., 1987). As noted above, this is
consistent with the predictions of our model: the inacti-
vation gate potentiates the effects of local anesthetics,
but is not necessary to generate those effects. There is
also evidence that at least some local anesthetic mole-
cules can be trapped by closure of the activation gate,
suggesting a possible mechanism for use-dependent
block that does not involve the fast-inactivation gate
(Strichartz, 1973; Yeh and Tanguy, 1985).
Gating-current studies have revealed that lidocaine
can produce a hyperpolarizing shift in the Q/V curve
(Hanck et al., 1994; Josephson and Chi, 1994) along
with a reduction in the total amount of on-gating cur-
rent. A possible interpretation of this finding is that
some of the voltage sensors of drug-bound channels
move outward at less depolarized potentials than nor-
mal. This would entail, at any given voltage, a drug-
induced rightward shift in the distribution of channels
along the activation pathway diagrammed in Fig. 8, as
our model predicts.
Finally, site-directed mutagenesis has placed the re-
ceptor for lidocaine roughly in the middle of the S6
transmembrane segment (Ragsdale et al., 1994). Ex-
trapolation to Na1 channels of a recent substituted cys-
teine accessibility study in segment S6 of Shaker K 1
channels (Liu et al., 1997) suggests that the position of
the activation gate is likely to be very close to the local
anesthetic binding site. Thus, it would not be surpris-
ing if the primary action of lidocaine is to interact with
activation gating, perhaps by stabilizing the channel in
the open conformation.
We wish to emphasize that our results are not suffi-
cient to determine uniquely our particular model of
lidocaine action. Although our results do suggest a very
limited role for fast inactivation in generating use-
dependent block, it is still possible that the affinity of
lidocaine for its receptor is increased by closure of the
fast-inactivation gate in the intact channel (i.e., with a
phenylalanine at site 1304). Another possibility is that
the Na1 channel slow inactivation mechanism plays a
role in lidocaine action. Our finding that recovery from
fast inactivation precedes recovery of the ionic current
in the presence of lidocaine parallels an earlier finding
that recovery from fast inactivation precedes recovery
from slow inactivation (Vedantham and Cannon, 1998),
and raises the possibility that the two slowly recovering
states are related in some way. For example, lidocaine
might accelerate the rate of entry into slow-inactivated
states.
Also, the mechanism of lidocaine action might vary
among sodium channel isoforms. Our experiments
were conducted in skeletal muscle sodium channels,
which have a lower apparent lidocaine affinity that car-
diac channels (Hille, 1978; Nuss et al., 1995). However,
most of this difference is attributable to relative shifts in16 Lidocaine and Na1 Channel Inactivation
voltage-dependent gating between the two isoforms,
rather than to differences in the putative binding site
(Wright et al., 1997), suggesting that our results with
skeletal muscle channels will probably hold for cardiac
channels as well. We should also emphasize that our re-
sults may not hold for all local anesthetics, which ex-
hibit considerable variation at the chemical level as well
as in their effects on sodium channels (Hille, 1977).
These uncertainties aside, our data do enable us to
place important new constraints on the possible forms
that models for lidocaine action can take. Any such
model must involve cooperativity between lidocaine
binding and fast inactivation, and must incorporate a
state that is slowly recovering, but not fast inactivated,
to explain use-dependent block. 
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